8-K: NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
8-K: Current report
8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | DEFA14A: Others
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | DEFA14A: Others
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | DEFA14A: Others
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | DEF 14A: Definitive information statements
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | PRE 14A: Preliminary proxy statements relating to merger or acquisition
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: Current report
No Data